Canadian company Phytokana Ingredients has secured $330 million in sales agreements for its fava bean products, supporting its upcoming commercial-scale facility in Alberta. These long-term offtake agreements with domestic and overseas companies, totaling $450 million, provide strong forward demand visibility for the company and validate its product performance and commercial strategy. This funding will enable Phytokana to process 30,000 tonnes of fava beans annually into protein concentrates and high-protein flours at its planned dry fractionation facility in Strathmore, Alberta.

Phytokana's fava bean products, including protein concentrates, flours, and starch flour, are meant for a variety of applications in the food industry, such as plant-based meats, alternative dairy, baked goods, and snack foods. The company sources its fava beans from Alberta's chernozemic soils and collaborates with universities to analyze new varieties and develop processes that enhance sensory, functional, and nutritional properties. Additionally, Phytokana is working on a government-backed project with Maia Farms to create myelium proteins using fava bean byproducts as fermentation media components, further showcasing its commitment to innovation and sustainability in the plant-based ingredient sector.